DUBLIN, July 13, 2023 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral…Original Article
FDA Approves Opill (norgestrel) OTC Daily Oral Contraceptive
